• Friday,September 20,2024
ururembotoursandtravel.com
X

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

$ 14.50

4.5 (259) In stock

Share

New ruthenium-xanthoxylin complex eliminates colorectal cancer

The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive

An ErbB-2 molecule unable to bind Hsp90 shows enhanced activity

Salinomycin decreases the CD44+/CD24- stem-like population during

Characterization of CTFs from BT474 cells and breast cancer

Effect of trastuzumab on tumor growth of HER2-overexpressing

PDF) Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab

Cancers, Free Full-Text

Biomolecules, Free Full-Text